JnJ eyes CDSCO nod for single shot COVID vaccine trials in 12-17 year olds MD Bureau20 Aug 2021 11:40 AM ISTNew Delhi: The American-based pharma major Johnson & Johnson (J&J) has applied to the Central Drugs Standard Control Organisation (CDSCO)...
Johnson and Johnson Rilematovir gets CDSCO panel okay for phase 3 trial Medical Dialogues Team18 Aug 2021 4:18 PM ISTNew Delhi: Global pharmaceuticals major Johnson and Johnson (JnJ) has got a go ahead from the Subject Expert Committee (SEC) of the Central Drugs...
JnJ cancer drug Amivantamab gets CDSCO panel okay with waiver of local phase 3,4 trials Medical Dialogues Team14 Aug 2021 3:25 PM ISTNew Delhi: Considering an unmet medical need in the country, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation...
JnJ gets DCGI emergency use approval for single dose COVID vaccine Ruchika Sharma7 Aug 2021 4:51 PM ISTNew Delhi: Johnson & Johnson's single-dose COVID-19 vaccine has been given Emergency Use approval in India, Union Health minister Mansukh...
Discussion between Govt, US manufacturers for procuring COVID vaccines not yet over: NTAGI Chief Ruchika Sharma3 Aug 2021 10:30 AM ISTNew Delhi: Discussions and negotiations are still not over between the government and US-based COVID-19 vaccine manufacturers for procuring their...
Still in talks with Indian govt on COVID vaccine: Johnson and Johnson Ruchika Sharma2 Aug 2021 5:56 PM ISTBengaluru: Johnson & Johnson said on Monday it was still in talks with the Indian government over its COVID-19 vaccine after the country's...
Janssen Pharma Selexipag gets USFDA nod to treat pulmonary arterial hypertension Ruchika Sharma2 Aug 2021 12:15 PM ISTTitusville: The Janssen Pharmaceutical Companies of Johnson & Johnson recently announced that the U.S. Food and Drug Administration (FDA) has...
JnJ single-shot COVID vaccine shelf life extended by USFDA to 6 months Ruchika Sharma29 July 2021 2:22 PM ISTNew Delhi: The U.S. Food & Drug Administration extended the shelf life for Johnson & Johnson's single-shot COVID-19 vaccine to six months...
Despite neurological illness reports, JnJ Covid-19 vaccine benefits outweigh risks: US CDC advisers Ruchika Sharma23 July 2021 12:45 PM ISTNew Delhi: Despite reports of a rare neurological disorder appearing in some people who have received Johnson & Johnson's COVID-19 vaccine, the...
Strong quarter from Johnson and Johnson as some operations return to normal Ruchika Sharma22 July 2021 9:30 AM ISTNew Delhi: Johnson & Johnson's second-quarter profit soared 73%, thanks to strong sales growth across all of its businesses, particularly its...
Johnson and Johnson exploring putting talc liabilities into bankruptcy: Report Ruchika Sharma19 July 2021 3:30 PM ISTNew Delhi: Johnson & Johnson is exploring a plan to offload liabilities from widespread Baby Powder litigation into a newly created business that...
Covid-19: JnJ, Pfizer yet to apply for license of vaccines in India Ruchika Sharma18 July 2021 9:15 AM ISTNew Delhi: The Drug Controller General of India (DCGI) has urged Pfizer, Johnson and Johnson twice in writing to apply for emergency use authorisation...
